AI in Biotech: Benefits, Real-World Applications & Use Cases

Artificial intelligence (AI) is increasingly integral to modern biotechnology, transforming sectors like drug discovery, genomics, and diagnostics by capitalizing on massive biological data, advanced computing power, and interdisciplinary collaboration. AI's integration into biotech has the potential to unlock significant economic value, particularly in the pharmaceutical industry, with projections of generating up to $410 billion by 2025. This technological convergence is revolutionizing drug development processes, clinical trials, precision medicine, and synthetic biology, offering efficiencies such as reduced drug development time, enhanced patient recruitment, and improved diagnostic accuracy. AI's role extends to environmental sustainability, optimizing agricultural yields and aiding in pollution monitoring. However, the field faces challenges related to data quality, explainability, energy demands, and regulatory frameworks. Sustainable AI infrastructure and responsible AI frameworks are becoming strategic necessities to address these issues. The future of AI in biotech points towards advancements in multimodal and agentic AI, quantum computing, and autonomous labs, which promise to further accelerate innovation and enhance accessibility in the industry.